Founded 11 years ago, the Company operates an end-to-end technology ecosystem for the execution of commercial programs in the pharmacy channel, connecting laboratories, pharmacies, and healthcare professionals through proprietary platforms (CRM, validator, and point-of-sale operational integration). The Company has built a strong market position and is currently a leading player in its segment.

The business model is scalable and proven, with over 5.5 million vouchers issued and a significant nationwide pharmacy presence, supported by a well-established network of ecosystem players and integrations with corporate systems.

Over the past 12 months, the Company has significantly accelerated its growth, achieving a CAGR of over 200% over the last three years, while maintaining high revenue recurrence and attractive margins — with clear upside potential through regional expansion and adjacent channels.

Market potential

The Digital Health market in Latin America is valued at USD 17B in 2024, with a strong projection to reach USD 58.8B by 2030. This growth is driven by rising healthcare costs, a shift toward patient-centric care, increasing demand for real-time data analytics and regulatory compliance, and the impact of generative AI — which is projected to increase healthcare worker productivity by up to 40%.

Within this landscape, the Health & Wellness sector in Latin America is expected to grow to USD 337M by 2034, highlighting a specific high-growth niche for the Company’s platform.

TAM
Includes Digital Health, Pharma Marketing, and health eCommerce
USD 30–40B in Latin America

SAM
Represents the segment accessible by geography and business model — approximately 30% of TAM
USD 9–12B (estimated)

SOM
The Company is currently in an active capture phase, targeting a significant market share within the next 3–5 yearsKey differentiators